Bentao Shi

438 total citations
25 papers, 292 citations indexed

About

Bentao Shi is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bentao Shi has authored 25 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Surgery and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bentao Shi's work include Renal cell carcinoma treatment (3 papers), MicroRNA in disease regulation (3 papers) and Urinary and Genital Oncology Studies (3 papers). Bentao Shi is often cited by papers focused on Renal cell carcinoma treatment (3 papers), MicroRNA in disease regulation (3 papers) and Urinary and Genital Oncology Studies (3 papers). Bentao Shi collaborates with scholars based in China and United States. Bentao Shi's co-authors include Boxing Su, Liqun Zhou, Zhongqiang Guo, Shangqi Yang, Wei Zhao, Xuesong Li, Xianxin Li, Xi Yu, Jinming Xu and Jin Liu and has published in prestigious journals such as Scientific Reports, Molecular Cancer and Cell Death and Disease.

In The Last Decade

Bentao Shi

25 papers receiving 287 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bentao Shi China 10 148 87 83 78 41 25 292
Raj Bhanvadia United States 7 107 0.7× 39 0.4× 70 0.8× 98 1.3× 29 0.7× 32 239
Hai Jiang China 8 232 1.6× 76 0.9× 22 0.3× 39 0.5× 46 1.1× 18 333
Liefu Ye China 10 130 0.9× 57 0.7× 53 0.6× 141 1.8× 50 1.2× 34 305
Sergio Serni Italy 10 99 0.7× 49 0.6× 45 0.5× 152 1.9× 35 0.9× 31 248
Bogdan Petruţ Romania 11 255 1.7× 230 2.6× 80 1.0× 106 1.4× 42 1.0× 41 431
Chenglin Yang China 12 86 0.6× 59 0.7× 90 1.1× 264 3.4× 122 3.0× 26 431
Zhengdong Hong China 13 284 1.9× 182 2.1× 40 0.5× 89 1.1× 94 2.3× 34 466
Yasaman Ramazani Belgium 5 176 1.2× 17 0.2× 43 0.5× 44 0.6× 28 0.7× 6 310
Angelo Cambio United States 9 119 0.8× 51 0.6× 95 1.1× 213 2.7× 46 1.1× 15 391
Andrzej Witek Poland 10 102 0.7× 63 0.7× 25 0.3× 25 0.3× 37 0.9× 57 292

Countries citing papers authored by Bentao Shi

Since Specialization
Citations

This map shows the geographic impact of Bentao Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bentao Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bentao Shi more than expected).

Fields of papers citing papers by Bentao Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bentao Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bentao Shi. The network helps show where Bentao Shi may publish in the future.

Co-authorship network of co-authors of Bentao Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Bentao Shi. A scholar is included among the top collaborators of Bentao Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bentao Shi. Bentao Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ye, Shuai, Tao Zhu, Mingxia Wang, et al.. (2025). Tumor-derived exosomal KPNA2 activates fibroblasts and interacts with KIFC1 to promote bladder cancer progression, a process inhibited by miR-26b-5p. Cellular & Molecular Biology Letters. 30(1). 20–20. 5 indexed citations
2.
Zhu, Tao, et al.. (2024). Bladder Cancer in Exosomal Perspective: Unraveling New Regulatory Mechanisms. International Journal of Nanomedicine. Volume 19. 3677–3695. 1 indexed citations
3.
Zhong-fu, Zhang, et al.. (2024). The relationship between oxidative balance score and erectile dysfunction in the U.S. male adult population. Scientific Reports. 14(1). 10746–10746. 6 indexed citations
4.
Zhang, Haiyu, et al.. (2024). Association between life’s essential 8 and male biochemical androgen deficiency: evidence from NHANES 2013–2016. Frontiers in Endocrinology. 15. 1369684–1369684. 2 indexed citations
5.
Su, Boxing, Wei Zhao, Bentao Shi, et al.. (2023). Editorial Expression of Concern: Let-7d suppresses growth, metastasis, and tumor macrophage infiltration in renal cell carcinoma by targeting COL3A1 and CCL7. Molecular Cancer. 22(1). 74–74. 2 indexed citations
6.
Xu, Jinming, et al.. (2023). ADAM12 promotes clear cell renal cell carcinoma progression and triggers EMT via EGFR/ERK signaling pathway. Journal of Translational Medicine. 21(1). 56–56. 17 indexed citations
7.
Xu, Jinming, et al.. (2023). Identification of ATP6V0A4 as a potential biomarker in renal cell carcinoma using integrated bioinformatics analysis. Oncology Letters. 26(3). 366–366. 1 indexed citations
8.
Xu, Jinming, et al.. (2022). SMARCC1 Enters the Nucleus via KPNA2 and Plays an Oncogenic Role in Bladder Cancer. Frontiers in Molecular Biosciences. 9. 902220–902220. 10 indexed citations
9.
Li, Weiqing, et al.. (2022). FAM107A as a Tumor Suppressor in Bladder Cancer Inhibits Cell Proliferation, Migration, and Invasion.. PubMed. 52(2). 260–268. 5 indexed citations
10.
Xu, Jinming, et al.. (2021). FAM64A is an androgen receptor-regulated feedback tumor promoter in prostate cancer. Cell Death and Disease. 12(7). 668–668. 15 indexed citations
11.
Li, Yifan, Lü Jin, Jiaju Liu, et al.. (2016). Bellini's duct carcinoma: A report of two cases and a review of the literature. Oncology Letters. 11(6). 3839–3841. 2 indexed citations
12.
Zheng, Aiping, et al.. (2016). Primary adrenal sarcomatoid carcinoma metastatic to the lung: Case report and review of the literature. Oncology Letters. 11(5). 3117–3122. 9 indexed citations
13.
Jing, Quan, Xiang Pan, Lü Jin, et al.. (2016). Urachal carcinoma: Report of two cases and review of the literature. Molecular and Clinical Oncology. 6(1). 101–104. 6 indexed citations
14.
Zhou, Jingcheng, Ran Cheng, Yan Wang, et al.. (2016). Aberrant expression of KPNA2 is associated with a poor prognosis and contributes to OCT4 nuclear transportation in bladder cancer. Oncotarget. 7(45). 72767–72776. 25 indexed citations
15.
CHEN, DUQUN, Bentao Shi, Lijun Zhou, et al.. (2015). Primary mesenchymal chondrosarcoma with bilateral kidney invasion and calcification in renal pelvis: A case report and review of the literature. Oncology Letters. 10(2). 1075–1078. 4 indexed citations
16.
Shi, Bentao, Boxing Su, Dong Fang, et al.. (2015). High expression of KPNA2 defines poor prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. BMC Cancer. 15(1). 380–380. 24 indexed citations
17.
Su, Boxing, Wei Zhao, Bentao Shi, et al.. (2014). Let-7d suppresses growth, metastasis, and tumor macrophage infiltration in renal cell carcinoma by targeting COL3A1 and CCL7. Molecular Cancer. 13(1). 206–206. 88 indexed citations
18.
CHEN, DUQUN, Yifan Li, Zuhu Yu, et al.. (2014). Investigating urachal carcinoma for more than 15 years. Oncology Letters. 8(5). 2279–2283. 24 indexed citations
19.
CHEN, DUQUN, Zuhu Yu, Liangchao Ni, et al.. (2014). Adenomatoid tumors of the testis: A report of two cases and review of the literature. Oncology Letters. 7(5). 1718–1720. 6 indexed citations
20.
Lai, Yongqing, et al.. (1969). Chronic scrotal pain caused by Mild Epididymitis: Report of a series of 44 cases. Pakistan Journal of Medical Sciences. 30(3). 638–41. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raj Bhanvadia Breakdown of academic impact, for papers by Hai Jiang Breakdown of academic impact, for papers by Liefu Ye Breakdown of academic impact, for papers by Sergio Serni Breakdown of academic impact, for papers by Bogdan Petruţ Breakdown of academic impact, for papers by Chenglin Yang Breakdown of academic impact, for papers by Zhengdong Hong Breakdown of academic impact, for papers by Yasaman Ramazani Breakdown of academic impact, for papers by Angelo Cambio Breakdown of academic impact, for papers by Andrzej Witek
Rankless by CCL
2026